Figure 2.
Role of ezetimibe in regulation of IL-17-producing immune cell populations in AS mice. (A) The numbers of CD4+IL-17+ (Th17), CD4+IFNγ+ (Th1), CD4+IL-4+ (Th2), CD4+CD25+Foxp3+ (Treg), CD1d+CD19+IL-17+ (B17), and CD1d+CD19+IL-10+ (B10) cells of mouse splenocytes were measured by ex vivo flow cytometry. (B) Gating strategy for IL-17-producing ILC3 cells. (C) IL-17+ ILCs in mouse splenocytes detected by flow cytometry. Values are means ± SEMs of three independent experiments. *p < 0.05.